Technical Analysis for TOCA - Tocagen Inc.

Grade Last Price % Change Price Change
grade B 12.39 0.41% 0.05
TOCA closed up 0.41 percent on Friday, November 16, 2018, on 37 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical TOCA trend table...

Date Alert Name Type % Chg
Nov 16 50 DMA Resistance Bearish 0.00%
Nov 16 Outside Day Range Expansion 0.00%
Nov 15 50 DMA Resistance Bearish 0.41%
Nov 15 MACD Bullish Centerline Cross Bullish 0.41%
Nov 15 Earnings Movers Other 0.41%
Nov 14 50 DMA Resistance Bearish 4.38%
Nov 14 20 DMA Support Bullish 4.38%
Nov 14 Earnings Movers Other 4.38%
Nov 13 50 DMA Resistance Bearish 1.72%
Nov 13 Wide Bands Range Expansion 1.72%

Older signals for TOCA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tocagen Inc. (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells. Its lead product candidates are vocimagene amiretrorepvec (Toca 511) and flucytosine extended release (Toca FC). Toca 511 is an investigational injectable retroviral replicating vector (RRV) that encodes a prodrug activator enzyme, cytosine deaminase (CD). Toca FC is an investigational extended-release version of 5-fluorocytosine (5-FC), a prodrug that is inactive as an anti-cancer drug. As of February, 2017, Tocagen has completed enrollment of the Phase II portion with 187 patients.
Is TOCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.8
52 Week Low 7.52
Average Volume 278,266
200-Day Moving Average 10.7827
50-Day Moving Average 12.4768
20-Day Moving Average 11.5075
10-Day Moving Average 12.137
Average True Range 0.985
ADX 12.95
+DI 15.8786
-DI 18.9571
Chandelier Exit (Long, 3 ATRs ) 10.545
Chandelier Exit (Short, 3 ATRs ) 12.755
Upper Bollinger Band 13.1034
Lower Bollinger Band 9.9116
Percent B (%b) 0.78
BandWidth 27.736693
MACD Line 0.0529
MACD Signal Line -0.0787
MACD Histogram 0.1316
Fundamentals Value
Market Cap 245.44 Million
Num Shares 19.8 Million
EPS -6.18
Price-to-Earnings (P/E) Ratio -2.00
Price-to-Sales 4252.02
Price-to-Book 2.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.98
Resistance 3 (R3) 13.88 13.26 13.72
Resistance 2 (R2) 13.26 12.85 13.31 13.63
Resistance 1 (R1) 12.82 12.60 13.04 12.92 13.54
Pivot Point 12.20 12.20 12.31 12.25 12.20
Support 1 (S1) 11.76 11.79 11.98 11.86 11.24
Support 2 (S2) 11.14 11.54 11.19 11.15
Support 3 (S3) 10.70 11.14 11.07
Support 4 (S4) 10.80